% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@INPROCEEDINGS{Bauer:908572,
author = {Bauer, E. K. and Stoffels, G. and Blau, T. and
Reifenberger, G. and Werner, J. M. and Lohmann, P. and Rapp,
M. and Fink, G. R. and Langen, K. and Galldiks, N.},
title = {{P}14.29 {P}rediction of overall survival in patients with
malignant glioma using dynamic
{O}-(2-[18{F}]-fluoroethyl)-{L}-tyrosine {PET}},
issn = {1523-5866},
reportid = {FZJ-2022-02696},
year = {2019},
abstract = {AbstractBACKGROUNDCharacterization of gliomas according to
the revised World Health Organization (WHO) classification
of 2016 has gained major importance regarding
prognostication. The present study aimed at exploring the
prognostic value of dynamic
O-(2-[18F]-fluoroethyl)-L-tyrosine (FET) PET in newly
diagnosed and molecularly defined astrocytic high-grade
glioma (HGG) of the WHO grades III or IV.MATERIAL AND
METHODSBefore initiation of treatment, dynamic FET PET
imaging was performed in patients with newly diagnosed
glioblastoma (GBM) and anaplastic astrocytoma (AA). Static
FET PET parameters such as maximum and mean tumor/brain
ratios (TBRmax/mean), as well as the dynamic FET PET
parameters time-to-peak (TTP) and slope, were obtained. The
predictive ability of FET PET parameters was evaluated with
regard to the overall survival (OS). Using ROC analyses,
threshold values for FET PET parameters were obtained.
Subsequently, univariate Kaplan-Meier and multivariate Cox
regression survival analyses were performed to assess their
predictive power for OS.RESULTSSixty patients (45 GBM, 15
AA) of two university centers were retrospectively
identified. Patients with a methylated MGMT promoter as well
as with an IDH mutation had a significantly longer OS (both
P<0.001). Furthermore, ROC analysis revealed in IDH-wildtype
HGG (n=45) that a TTP>25 minutes (AUC, 0.90; sensitivity,
$90\%;$ specificity, $87\%;$ P<0.001) was highly prognostic
for a longer OS (29 vs. 12 months; P<0.001). Besides a
complete resection and a methylated MGMT promoter, TTP
remained significant in the multivariate survival analysis
(P=0.002, P=0.016, and P=0.003, respectively), indicating an
independent predictor for OS. In contrast, both TBRmax and
TBRmean were not prognostic (AUC, 0.37 and 0.32,
respectively).CONCLUSIONData suggest that within the
subgroup of patients with newly diagnosed and untreated
IDH-wildtype GBM and AA, dynamic FET PET additionally allows
the identification of patients with an improved OS.},
month = {Sep},
date = {2019-09-19},
organization = {14th Meeting of the European
Association of Neuro-Oncology, Lyon
(France), 19 Sep 2019 - 22 Sep 2019},
cin = {INM-4 / IEK-5 / INM-3},
ddc = {610},
cid = {I:(DE-Juel1)INM-4-20090406 / I:(DE-Juel1)IEK-5-20101013 /
I:(DE-Juel1)INM-3-20090406},
pnm = {5253 - Neuroimaging (POF4-525)},
pid = {G:(DE-HGF)POF4-5253},
typ = {PUB:(DE-HGF)1},
UT = {WOS:000493085900266},
doi = {10.1093/neuonc/noz126.264},
url = {https://juser.fz-juelich.de/record/908572},
}